[go: up one dir, main page]

CN110129243B - Soy yogurt suitable strains, inoculants and their applications - Google Patents

Soy yogurt suitable strains, inoculants and their applications Download PDF

Info

Publication number
CN110129243B
CN110129243B CN201910534345.8A CN201910534345A CN110129243B CN 110129243 B CN110129243 B CN 110129243B CN 201910534345 A CN201910534345 A CN 201910534345A CN 110129243 B CN110129243 B CN 110129243B
Authority
CN
China
Prior art keywords
lactobacillus
microbial inoculum
scb0469
lactococcus lactis
cfu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910534345.8A
Other languages
Chinese (zh)
Other versions
CN110129243A (en
Inventor
方祥
余建英
郑勇
王洁
廖振林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Agricultural University
Original Assignee
South China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Agricultural University filed Critical South China Agricultural University
Priority to CN201910534345.8A priority Critical patent/CN110129243B/en
Publication of CN110129243A publication Critical patent/CN110129243A/en
Application granted granted Critical
Publication of CN110129243B publication Critical patent/CN110129243B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/06Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/125Casei
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/147Helveticus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/157Lactis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/165Paracasei
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/169Plantarum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/175Rhamnosus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/21Streptococcus, lactococcus
    • A23V2400/249Thermophilus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to the technical field of microorganisms, in particular to a bean yogurt adaptive strain, a microbial inoculum and application thereof. The soy yogurt adaptive strain is selected from any one or more of the following strains: 1) lactobacillus rhamnosus SCB0119, the preservation number is: CGMCC 17618; 2) lactococcus lactis SCB0469 with the deposit number: CGMCC 17619; 3) lactobacillus helveticus SCB0641 with a collection number of: CGMCC 17620; all three strains are preserved in China center for culture Collection of microorganisms for 24 days at 4 months in 2019. The microbial inoculum is obtained by reasonable compatibility, and the mixed soybean milk is fermented to obtain the soybean yogurt with good curd effect and good flavor, and the soybean isoflavone can be biologically converted to improve the content of free soybean isoflavone aglycone.

Description

Soybean yogurt adaptive strain, microbial inoculum and application thereof
Technical Field
The invention relates to the technical field of microorganisms, in particular to a bean yogurt adaptive strain, a microbial inoculum and application thereof.
Background
The traditional yoghourt is an animal fermented food which is obtained by taking fresh milk or reconstituted milk as a raw material and carrying out processing by process technologies such as blending, homogenizing, sterilizing, cooling, inoculating a leavening agent and the like and microbial fermentation. The bean yoghourt is a plant (or animal) fermented food which is obtained by taking fresh soybean milk or recovered soybean milk as a raw material, adding or not adding fresh milk or recovered milk, processing by the process technologies of blending, homogenizing, sterilizing, cooling, inoculating a leavening agent and the like, and fermenting by microorganisms.
After the fresh milk or the reconstituted milk is added in the preparation of the bean yoghourt, compared with the traditional yoghourt, the soybean yoghourt combines the advantages of the milk and the soybean and simultaneously makes up the defects of the milk and the soybean, and has more comprehensive and rich protein types, amino acid compositions, fat types and vitamin types and more balanced nutrition. The addition of the milk makes up the defects of poor curding capability, strong beany flavor and poor taste and flavor when the soybean milk is simply fermented, and the existence of the soybean milk makes up the defect that the traditional yoghurt lacks dietary fibers, and particularly brings the natural active substances of soybean isoflavone to the soybean yoghurt.
The soybean isoflavone is a natural active substance existing in soybeans, has various active effects of protecting cardiovascular system, preventing atherosclerosis, preventing osteoporosis, relieving female climacteric symptoms, resisting tumor and oxidation, protecting nerves, regulating immunity, protecting liver and the like, and has excellent application prospect and market prospect. At present, some organizations in Japan propose that the upper limit of the intake of soybean isoflavone in daily diet is 70-75 mg/d, and the upper limit of the intake of soybean isoflavone added outside diet is 30 mg/d. In European Union, the recommended intake of soybean isoflavone is 40-100 mg/d according to EC 1924/2006.
Under natural conditions, the content of soybean isoflavone in soybeans is about 0.1-0.5%, 12 isomers are generally considered, including 9 bound glycosides mainly comprising daidzin, genistin and the like and 3 free-type aglycones comprising daidzein, genistein and glycitein, wherein the bound glycoside accounts for 97-98%, and the free-type aglycone only accounts for 2-3%. Change and Nair (1995) found that soybean isoflavone glycoside is difficult to be absorbed and utilized by human body, compared with soybean isoflavone aglycone which is easier to be absorbed and utilized by human body. Xu et al (1995) and Wei et al (1996) have suggested that soybean isoflavone aglycones have higher biological activity than soybean isoflavone glycosides, and that soybean isoflavones have multiple active effects when present in the aglycone form. The soybean isoflavone glycoside can be hydrolyzed into soybean isoflavone aglycone by beta-glucosidase secreted by part of intestinal microorganisms, but the composition of intestinal flora varies from person to person, so that the conditions of synthesizing and secreting the beta-glucosidase and converting the soybean isoflavone in a human body are different, and the amount of the soybean isoflavone aglycone which is finally converted is limited. In conclusion, the biological conversion of the soybean isoflavone can effectively improve the biological activity and the bioavailability of the soybean isoflavone in the organism, and has very important significance.
According to data records of soybean germplasm resource databases of the institute of crop science of the academy of agricultural sciences of China and soybean germplasm resource databases of the department of agriculture of the United states, the content of protein in soybeans is 30.8-57.9%, the soybean protein is high-quality protein like milk protein, and the soybean protein mainly comprises albumin (accounting for about 10%) and globulin (accounting for about 90%). According to immunological analysis, globulin contains 40% of glycinin and 30% of beta-conglycinin, which are main antigen proteins in soybean and are easy to cause adverse reactions such as allergy and the like. However, the two antigen proteins have stronger heat stability, and the heat treatment at the temperature of 100 ℃ has little influence on the antigen activity. Therefore, researchers have turned to methods for removing antigenic proteins, and have improved the nutritional properties of soy products by reducing their antigenic activity through fermentation with microorganisms such as lactic acid bacteria.
In view of the above, the present invention is particularly proposed.
Disclosure of Invention
The invention aims to provide a soy yogurt adaptive strain, which can biologically convert soy isoflavone, thereby improving the content of aglycon soy isoflavone components and improving the biological activity and bioavailability in a body.
The second purpose of the invention is to provide a bean yoghourt adaptive microbial inoculum, which can be used for bean yoghourt adaptive fermentation after the bacterial strain is scientifically matched, reduce the content of antigen protein in the bean yoghourt, and release and improve the nutrition of the bean yoghourt.
The third purpose of the invention is to provide the application of the bean yoghourt adaptive microbial inoculum in the preparation of the bean yoghourt, and the bean yoghourt prepared by using the bean yoghourt adaptive microbial inoculum can obtain good curd effect and improve the flavor of the bean yoghourt.
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
a soy yogurt-compatible strain selected from any one or more of the following strains:
a) lactococcus lactis SCB0469, Lactococcus lactis, deposited in the China general microbiological culture Collection center, with the deposit numbers: CGMCC 17619; the preservation time is as follows: 24 months 4 in 2019;
b) lactobacillus rhamnosus SCB0119, Lactobacillus rhamnosus, preserve in China center for culture of microorganisms, the preserving number is: CGMCC 17618; the preservation time is as follows: 24 months 4 in 2019;
c) lactobacillus helveticus SCB0641, Lactobacillus helveticus, is preserved in China center for culture of microorganisms with the preservation number: CGMCC 17620; the preservation time is as follows: 24/4/2019.
The morphological description characteristics of each strain are respectively as follows: a colony morphology chart obtained after lactobacillus rhamnosus SCB0119 strain is inoculated on an MRS solid culture medium and cultured for 72 hours at the temperature of 37 ℃. The colony diameter is 1.48-2.75mm, and the colony is round, white, glossy, opaque, moist, low around the middle bulge, and smooth and complete edge.
A colony morphology obtained after the lactococcus lactis strain SCB0469 was inoculated on an MRS solid medium and cultured at a temperature of 30 ℃ for 72 hours. The colony diameter is 1.42-2.90mm, and the colony is round, white, glossy, slightly transparent, moist, slightly convex in the middle, low in periphery, smooth and complete in edge.
A colony morphology obtained after lactobacillus helveticus SCB0641 strain was inoculated on MRS solid medium and cultured at 37 ℃ for 72 hours. The colony diameter is 1.35-2.20mm, and the colony is round, white, glossy, slightly transparent, slightly moist, low in middle protrusion, smooth and complete in edge.
The 16SrDNA sequence of Lactobacillus rhamnosus (Lactobacillus rhamnosus) SCB0119 has 1380 nucleotides, and the sequence is shown as SEQ ID NO: 1 is shown.
The 16SrDNA sequence of Lactococcus lactis (Lactococcus lactis) SCB0469 has 1419 nucleotides, and the sequence is shown as SEQ ID NO: 2, respectively.
The 16SrDNA sequence of Lactobacillus helveticus (Lactobacillus helveticus) SCB0641 has 1409 nucleotides, and the sequence is shown as SEQ ID NO: 3, respectively.
The three strains are all preserved in the China general microbiological culture Collection center, and the preservation addresses are as follows: xilu No. 1, Beijing, Chaoyang, Beijing, and institute for microbiology, China academy of sciences.
The lactococcus lactis SCB0469 has the main effects of serving as a soy yogurt flavor strain and improving the flavor of soy yogurt, the lactobacillus rhamnosus SCB0119 has the main effects of removing antigen protein in soy milk and converting soy isoflavone, and the lactobacillus helveticus SCB0641 has the main effects of converting soy isoflavone and improving the content of aglycone soy isoflavone in the soy yogurt.
The bean yoghurt adaptive strain is a safe edible strain which has any one or more of the following effects by fermenting pure bean milk (or mixed bean milk): (1) can produce pleasant flavor, (2) can effectively remove anti-nutritional factors, and (3) can biologically convert the soybean isoflavone to improve the content of the aglycone soybean isoflavone so as to improve the biological activity and the bioavailability of the aglycone soybean isoflavone.
According to the strain provided by the invention, the strain number of the lactobacillus rhamnosus is SCB0119, the strain number of the lactococcus lactis is SCB0469, and the strain number of the lactobacillus helveticus is SCB 0641.
The lactobacillus rhamnosus SCB0119 provided by the invention is separated from Sichuan pickle and is obtained by dilution and pouring plate separation.
The lactococcus lactis SCB0469 provided by the invention is separated from Russian kefir and is obtained by dilution and pouring on a plate.
The Lactobacillus helveticus SCB0641 provided by the invention is separated from Tibetan spiritual mushroom by a dilution and pouring plate method.
The invention claims the bean yoghourt adaptive strain with the preservation number and the mutant strain which has mutation in a moderate range and still has strong bean yoghourt adaptive capability.
In the practical application process, the bean yoghourt adaptive strain can be expanded and cultured to form a composition, namely a bean yoghourt adaptive starter (or a bean yoghourt adaptive microbial inoculum) which is in the form of a microbial inoculum so as to expand the application range of the bean yoghourt adaptive bacterial strain in consideration of the possible transportation and other reasons.
The bean yoghourt adaptive starter is a bean yoghourt direct vat set type freeze-dried starter prepared by 2 or more lactic acid bacteria strains which are prepared by scientifically matching bean yoghourt adaptive strains, can generate pleasant flavor, can biologically convert soybean isoflavone to improve the content of aglycon type soybean isoflavone so as to improve the biological activity and the bioavailability and/or can effectively remove anti-nutritional factors and improve the nutritional efficacy of the bean yoghourt.
The invention also provides a microbial inoculum containing the strain.
In some embodiments of the present invention, the microbial inoculum may further include any one or more of streptococcus thermophilus, lactobacillus plantarum, lactobacillus casei and lactobacillus paracasei.
In some embodiments of the present invention, the microbial inoculum preferably comprises at least lactococcus lactis SCB 0469.
The strain can be the existing strain, and can improve the fermentation effect and the like by being matched with the strain obtained by separation.
Specifically, the streptococcus thermophilus, the lactobacillus plantarum, the lactobacillus casei and the lactobacillus paracasei can be used as the bacteria for fermenting the common yoghourt.
In some specific embodiments of the invention, in the microbial inoculum, the ratio of the lactobacillus rhamnosus SCB0119 to the lactobacillus lactis SCB0469 to the lactobacillus helveticus SCB0641 is (0-1.22 × 10) in terms of the number of viable bacteria10)﹕ (1.0×106~3.60×1010)﹕(0~8.55×1010). Preferably, the ratio of the three bacteria in the microbial inoculum is (1X 10) in terms of viable count7~8×109)﹕(1×107~8×109)﹕(1×107~8×109) (ii) a More preferably, the ratio of the three bacteria in the microbial inoculum is (6.5X 10) in terms of viable count7~6×109)﹕(1.2×107~5.5×109)﹕(1.8×107~ 4×109)。
In some specific embodiments of the invention, in the microbial inoculum, the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus lactis SCB0469, the lactobacillus helveticus SCB0641 and the streptococcus thermophilus is (0-1.22 × 10) in terms of the number of viable bacteria10) ﹕(1.0×106~3.60×1010)﹕(0~8.55×1010)﹕(0~4.54×109). Preferably, the ratio of the four bacteria in the microbial inoculum is (1X 10) in terms of viable count7~8×109)﹕(1×107~8×109)﹕(1×107~8×109) ﹕(1×106~4×109) (ii) a More preferably, the ratio of the four bacteria in the microbial inoculum is (6.5X 10) in terms of viable count7~6×109) ﹕(1.2×107~5.5×109)﹕(1.8×107~4×109)﹕(3×106~3×109)。
The specific implementation mode of the invention provides several scientific compatibility modes, which are as follows:
the microbial inoculum comprises Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469 and Lactobacillus paracasei. The ratio of Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469 and Lactobacillus paracasei is preferably (6.5X 10) in terms of viable count7~3.0×109)﹕(1.5×108~5.0×109) ﹕(1.5×108~3.0×109)﹕(4.0×108~7.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus. Further preferably, the microbial inoculum also comprises lactobacillus plantarum and/or lactobacillus casei.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactococcus lactis SCB0469, the lactobacillus paracasei and the streptococcus thermophilus in the microbial inoculum is (6.5 multiplied by 10)7~2.5×109)﹕(4.0×108~4.0×109)﹕(1.5×108~2.5×109)﹕ (4.5×108~7.0×109)﹕(2.0×107~3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469, Lactobacillus paracasei, and Streptococcus thermophilus is (9.0 × 10) based on the number of viable bacteria7~5.0×108)﹕(4.0×108~8.0×108)﹕ (1.5×108~5.0×108)﹕(1.0×109~7.0×109)﹕(2.0×107~6.0×107)。
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactococcus lactis SCB0469, the lactobacillus paracasei, the streptococcus thermophilus, the lactobacillus plantarum and the lactobacillus casei in the microbial inoculum is (6.5 multiplied by 10)7~2.5×109)﹕(4.0×108~4.0×109)﹕ (1.5×108~2.5×109)﹕(4.5×108~7.0×109)﹕(2.0×107~3.0×109)﹕(3.0×108~ 5.0×109)﹕(5.5×108~5.5×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469, Lactobacillus paracasei, Streptococcus thermophilus, Lactobacillus plantarum, and Lactobacillus casei is (3.5 × 10) based on the number of viable bacteria8~2.5×109)﹕(4.0×108~ 4.0×109)﹕(1.5×108~2.5×109)﹕(4.5×108~5.5×109)﹕(1.0×108~3.0×109) ﹕(3.0×108~5.0×109)﹕(5.5×108~5.5×109)。
The microbial inoculum comprises lactococcus lactis SCB0469 and Lactobacillus helveticus SCB 0641. The ratio of lactococcus lactis SCB0469 to Lactobacillus helveticus SCB0641 is preferably (1.2X 10) in terms of the number of viable bacteria7~2.5×109)﹕(1.8×107~ 4.0×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus and/or lactobacillus paracasei.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactococcus lactis SCB0469, the Lactobacillus helveticus SCB0641 and the Streptococcus thermophilus is (1 multiplied by 10) in terms of the number of the viable bacteria in the microbial inoculum7~2.5×109)﹕(1.5×107~ 4.0×109)﹕(3×106~3×109). Preferably, in the present inventionIn some embodiments, the ratio of the viable bacteria count of the lactococcus lactis SCB0469, the Lactobacillus helveticus SCB0641 and the Streptococcus thermophilus is (1.2 × 10)7~1.5×107) ﹕(1.8×107~2.5×107)﹕(3×106~8×106). Or the ratio of Lactobacillus helveticus SCB0641, Lactobacillus paracasei and lactococcus lactis SCB0469 in terms of viable count in the microbial inoculum is (3.0 × 10)8~5.0×109): (4.0×108~5.5×109)﹕(1.5×108~2.5×109). More preferably, the ratio of the lactobacillus helveticus SCB0641, the lactobacillus paracasei SCB0469 and the streptococcus thermophilus in the microbial inoculum is (4.0 × 10) in terms of the number of the viable bacteria8~4.0×109):(4.5×108~5.5×109)﹕(1.5×108~2.5×109)﹕(1.0×108~ 3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus helveticus SCB0641, Lactobacillus paracasei, lactococcus lactis SCB0469, Streptococcus thermophilus (4.0X 10) is calculated by the number of viable bacteria8~6.0×108): (4.5×108~9.5×108)﹕(6×108~1.0×109)﹕(5.0×108~1.5×109)。
The microbial inoculum comprises Lactobacillus rhamnosus SCB0119 and Lactobacillus lactis SCB 0469. In the microbial inoculum, the ratio of Lactobacillus rhamnosus SCB0119 to lactococcus lactis SCB0469 is preferably (6.5 multiplied by 10) in terms of the number of viable bacteria7~6×109) ﹕(1.5×108~3.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus rhamnosus SCB0119, the lactococcus lactis SCB0469 and the streptococcus thermophilus is (6.5 multiplied by 10) in terms of the number of the viable bacteria in the microbial inoculum7~6×109)﹕(1.5×108~ 3.5×109)﹕(2×107~3×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus rhamnosus SCB0119, lactococcus lactis SCB0469 and Streptococcus thermophilus, based on the number of viable bacteria, is: (1×109~6×109)﹕ (1×109~3.5×109)﹕(8×107~8×108)。
The microbial inoculum comprises lactobacillus casei and lactococcus lactis SCB 0469. In the microbial inoculum, the ratio of lactobacillus casei to lactococcus lactis SCB0469 is preferably (4 × 10) in terms of viable count8~8×109)﹕(1×108~2.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus casei, the lactococcus lactis SCB0469 and the streptococcus thermophilus in the microbial inoculum is (5.5 multiplied by 10) in terms of viable count8~5.5×109)﹕(1.5×108~2.5×109) ﹕(4×107~3×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus casei, lactococcus lactis SCB0469 and Streptococcus thermophilus is (1.0X 10) based on the number of viable bacteria9~5.5×109)﹕(9×108~2.5×109) ﹕(4×107~8×107)。
The microbial inoculum comprises lactobacillus paracasei and lactococcus lactis SCB 0469. In the microbial inoculum, the ratio of lactobacillus paracasei to lactococcus lactis SCB0469 is (3 multiplied by 10) in terms of the number of viable bacteria8~7.0×109)﹕(1.5×108~2.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus paracasei, the lactococcus lactis SCB0469 and the streptococcus thermophilus in the microbial inoculum is (4.5 multiplied by 10)8~7.0×109)﹕(1.5×108~ 2.5×109)﹕(2.0×107~3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus paracasei, lactococcus lactis SCB0469 and Streptococcus thermophilus is (1X 10) based on the number of viable bacteria9~7.0×109) ﹕(2×108~6×108)﹕(1×108~8×108)。
The microbial inoculum comprises lactobacillus plantarum and lactococcus lactis SCB 0469. The ratio of Lactobacillus plantarum to lactococcus lactis SCB0469 in terms of viable count in the microbial inoculum is preferably (3 × 10)8~8×109)﹕(1.5×108~8.0×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus plantarum to the lactococcus lactis SCB0469 to the streptococcus thermophilus is (3 x 10) in terms of the number of viable bacteria in the microbial inoculum8~5×109)﹕(1.5×108~5.5×109)﹕ (1.0×108~3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus plantarum, lactococcus lactis SCB0469, and Streptococcus thermophilus is (3X 10) in terms of viable count8~6×108)﹕(1×109~5.5×109) ﹕(1.0×108~3.0×109)。
In different embodiments, the bacterial agent can be 0, 1 × 10 and 1 × 10 in terms of the number of active bacteria of lactobacillus rhamnosus SCB01197cfu/L、2×107cfu/L、3×107cfu/L、4×107cfu/L、5×107cfu/L、6×107cfu/L、 7×107cfu/L、8×107cfu/L、9×107cfu/L、1×108cfu/L、2×108cfu/L、3×108cfu/L、 4×108cfu/L、5×108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、9×108cfu/L、 1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、5×109cfu/L、6×109cfu/L、 7×109cfu/L、8×109cfu/L、9×109cfu/L、1×1010cfu/L、1.22×1010cfu/L, etc.;
lactococcus lactis SCB0469 may be: 1.0X 106cfu/L、2×106cfu/L、3×106cfu/L、 4×106cfu/L、5×106cfu/L、6×106cfu/L、7×106cfu/L、8×106cfu/L、9×106cfu/L、 1×107cfu/L、2×107cfu/L、3×107cfu/L、4×107cfu/L、5×107cfu/L、6×107cfu/L、 7×107cfu/L、8×107cfu/L、9×107cfu/L、1×108cfu/L、2×108cfu/L、3×108cfu/L、 4×108cfu/L、5×108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、9×108cfu/L、 1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、5×109cfu/L、6×109cfu/L、 7×109cfu/L、8×109cfu/L、9×109cfu/L、1×1010cfu/L、2×1010cfu/L、3×1010cfu/L、 3.6×1010cfu/L, etc.;
lactobacillus helveticus SCB0641 can be 0, 1 × 107cfu/L、2×107cfu/L、3×107cfu/L、 4×107cfu/L、5×107cfu/L、6×107cfu/L、7×107cfu/L、8×107cfu/L、9×107cfu/L、 1×108cfu/L、2×108cfu/L、3×108cfu/L、4×108cfu/L、5×108cfu/L、6×108cfu/L、 7×108cfu/L、8×108cfu/L、9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、 4×109cfu/L、5×109cfu/L、6×109cfu/L、7×109cfu/L、8×109cfu/L、9×109cfu/L、 1×1010cfu/L、2×1010cfu/L、3×1010cfu/L、4×1010cfu/L、5×1010cfu/L、6×1010cfu/L、7×1010cfu/L、8×1010cfu/L、8.55×1010cfu/L, etc.;
the Streptococcus thermophilus can be 0, 1 × 106cfu/L、2×106cfu/L、3×106cfu/L、4×106cfu/L、 5×106cfu/L、6×106cfu/L、7×106cfu/L、8×106cfu/L、9×106cfu/L、1×107cfu/L、 2×107cfu/L、3×107cfu/L、4×107cfu/L、5×107cfu/L、6×107cfu/L、7×107cfu/L、 8×107cfu/L、9×107cfu/L、1×108cfu/L、2×108cfu/L、3×108cfu/L、4×108cfu/L、 5×108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、9×108cfu/L、1×109cfu/L、 2×109cfu/L、3×109cfu/L、4×109cfu/L、4.54×109cfu/L, etc.;
the lactobacillus paracasei can be 0, 4 × 108cfu/L、5×108cfu/L、6×108cfu/L、7×108cfu/L、 8×108cfu/L、9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、 5×109cfu/L、6×109cfu/L、7×109cfu/L、7.5×109cfu/L, etc.;
the Lactobacillus plantarum can be 0, 3 × 108cfu/L、4×108cfu/L、5×108cfu/L、6×108cfu/L、 7×108cfu/L、8×108cfu/L、9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、 4×109cfu/L、5×109cfu/L, etc.;
the Lactobacillus casei can be 0, 5.5 × 108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、 9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、5×109cfu/L、 5.5×109cfu/L, and so on.
The microbial inoculum is obtained by scientific compatibility of the strains, can be used for fermenting and mixing the soybean milk, improves the curd effect and the flavor of the obtained soybean yogurt, can improve the conversion rate of the soybean isoflavone in the soybean yogurt, has high content of free soybean isoflavone aglycone, and has better activity function.
The soybean protein content is 30.8-57.9%, and the soybean protein can be mainly classified into albumin (accounting for about 10%) and globulin (accounting for about 90%). According to immunological analysis, globulin contains 40% of glycinin and 30% of beta-conglycinin, which are main antigen proteins in soybean and are easy to cause adverse reactions such as allergy and the like. However, the two antigen proteins have stronger heat stability, and the heat treatment at the temperature of 100 ℃ has little influence on the antigen activity. The microbial inoculum obtained by the scientific compatibility can also reduce the antigen activity of the soybean yoghourt, thereby improving the nutritional characteristics of the soybean product.
The invention also provides application of the microbial inoculum in preparation of the bean yoghourt.
When the microbial inoculum is used for preparing the soybean yoghourt, the soybean isoflavone glycoside can be converted into soybean isoflavone aglycone so as to play stronger biological activity and health care effect; meanwhile, the bean yoghourt prepared by the microbial inoculum has milk fragrance and bean fragrance, basically eliminates beany flavor, and has better flavor compared with the existing bean yoghourt products on the market.
Preferably, the method for preparing the bean yoghourt comprises the following steps: inoculating the microbial inoculum into the sterilized mixed soybean milk, and fermenting.
Preferably, the inoculation amount of the microbial inoculum in the mixed soybean milk is 3.0 multiplied by 107~9.6×1010cfu/L。
Preferably, the temperature of the fermentation is 25-45 ℃. The fermentation time is 5-24 h.
Preferably, the fermentation is followed by a cold storage after-ripening treatment. More preferably, the refrigerating temperature is 3-5 ℃. The time for cold storage is preferably 6 hours or more than 6 hours.
Preferably, the mixed soybean milk is mainly prepared by mixing a milk matrix and a soybean matrix. More preferably, the mixed soybean milk further comprises a sweetener, and the sweetener is preferably sucrose.
Preferably, the milk base comprises any one or more of fresh milk, powdered milk and condensed milk.
Preferably, the soy base comprises any one or more of fresh soy milk and soy flour.
Preferably, the preparation method of the mixed soybean milk comprises the following steps: mixing 1-8 parts by weight of milk powder, 3-11 parts by weight of bean flour and 1-12 parts by weight of cane sugar with drinking water to obtain 100 parts by weight of materials, and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; or the preparation method of the mixed soybean milk comprises the following steps: mixing 30-50 parts by weight of fresh milk, 40-70 parts by weight of fresh soybean milk and 1-12 parts by weight of sucrose to obtain 100 parts by weight of materials, and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; or the preparation method of the mixed soybean milk comprises the following steps: mixing 1-8 parts by weight of milk powder, 40-60 parts by weight of fresh soybean milk and 1-12 parts by weight of cane sugar with drinking water to obtain 100 parts by weight of material, and uniformly stirring to completely dissolve the material to obtain mixed soybean milk; or the preparation method of the mixed soybean milk comprises the following steps: 30-50 parts by weight of fresh milk, 3-11 parts by weight of bean flour and 1-12 parts by weight of cane sugar are mixed with drinking water to obtain 100 parts by weight of materials, and the materials are uniformly stirred to be completely dissolved to obtain the mixed soybean milk.
The fresh soybean milk is preferably prepared according to a soybean-water weight ratio of 1: 6-1: 10.
The invention mixes the milk matrix and the bean matrix, and the nutritional components of the product are more comprehensive and balanced.
Compared with the prior art, the invention has the beneficial effects that:
the invention separates and identifies the strains with the suitability of the soy milk, obtains the microbial inoculum through reasonable compatibility, ferments the mixed soy milk, can obtain the soy milk with good curd effect and good flavor, can remove part of antigen protein, biologically converts the soy isoflavone, has high content of free soy isoflavone aglycone, and improves the biological activity and the biological utilization rate of the soy isoflavone in the organism.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are some embodiments of the present invention, and other drawings can be obtained by those skilled in the art without creative efforts.
FIG. 1 is a graph showing the comparison of different strains in Experimental example 2 of the present invention with aglycone-producing soybean isoflavones;
FIG. 2 is a graph showing the comparison of the content of the antigen protein after the fermentation of soybean milk by different strains in Experimental example 2 of the present invention;
FIG. 3 is a graph showing the content of soy isoflavones in the mixed soymilk before fermentation in example 3 of the present invention; wherein D represents daidzin, G represents genistin, DE represents daidzein, and GE represents genistein;
FIG. 4 is a graph showing the content of soy isoflavones in soy yogurt obtained by fermentation using a microbial inoculum in example 3 of the present invention;
FIG. 5 is a graph showing the change in the isoflavone content before and after fermentation with the microbial inoculum in example 3 of the present invention.
The bean yogurt adaptive strain provided by the application comprises the following components:
a) lactococcus lactis (Lactococcus lactis), strain number is SCB0469, and the deposit number is: CGMCC 17619;
b) lactobacillus rhamnosus (Lactobacillus rhamnosus), strain number SCB0119, accession number: CGMCC 17618;
c) lactobacillus helveticus (Lactobacillus helveticus), strain number SCB0641, collection number: CGMCC 17620;
are all preserved in China general microbiological culture Collection center, and the preservation addresses are as follows: western road No. 1, north west city of township, beijing, institute of microbiology, china academy of sciences; the strains were detected as viable by the depository at 24/4.2019 and deposited.
Detailed Description
The technical solutions of the present invention will be clearly and completely described below with reference to the accompanying drawings and the detailed description, but those skilled in the art will understand that the following described embodiments are some, not all, of the embodiments of the present invention, and are only used for illustrating the present invention, and should not be construed as limiting the scope of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
The lactobacillus rhamnosus SCB0119 is separated from Sichuan pickle;
lactococcus lactis SCB0469 of the present invention was isolated from Russian kefir;
the lactobacillus helveticus SCB0641 of the present invention is isolated from tibetan pleurotus nebrodensis.
The streptococcus thermophilus, the lactobacillus plantarum, the lactobacillus casei and the lactobacillus paracasei adopted in the specific embodiment of the invention can be: streptococcus thermophilus CGMCC1.6472, Lactobacillus plantarum CGMCC1.573, Lactobacillus casei CGMCC1.8727, and Lactobacillus paracasei CGMCC 1.9088.
Example 1
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises four strains of lactococcus lactis SCB0469, Lactobacillus rhamnosus SCB0119, Streptococcus thermophilus and Lactobacillus helveticus SCB0641, wherein the ratio of the lactococcus lactis SCB0469, the Lactobacillus rhamnosus SCB0119, the Streptococcus thermophilus and the Lactobacillus helveticus SCB0641 is 2.0 multiplied by 10 in terms of the number of active bacteria9﹕4.0×109﹕2.5×108﹕8.0×109
The four strains are mixed in proportion to obtain the bean yoghourt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) taking 2kg of milk powder, 9kg of pure soybean powder and 6kg of cane sugar, adding 100kg of drinking water, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milkCooling to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 8.5 multiplied by 109cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature, wherein the fermentation temperature is 42 ℃, and the fermentation time is 8 hours; and after fermentation is finished, refrigerating and ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating time is more than 12 hours, so that the bean yoghourt is obtained.
Example 2
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactococcus lactis SCB0469, streptococcus thermophilus and lactobacillus helveticus SCB0641, wherein the ratio of the lactococcus lactis SCB0469, the streptococcus thermophilus and the lactobacillus helveticus SCB0641 is 1.2 multiplied by 10 in terms of the number of live bacteria7﹕3.0×106﹕1.8×107
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) taking 3kg of milk powder, 8kg of pure soybean powder and 6kg of cane sugar, adding 100kg of drinking water, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milk to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 3 multiplied by 107cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature for 24h at 25 ℃; and after fermentation is finished, refrigerating and ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating time is more than 12 hours, so that the bean yoghourt is obtained.
Example 3
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactobacillus rhamnosus SCB0119, lactococcus lactis SCB0469 and streptococcus thermophilus, and the lactobacillus rhamnosus SCB0119 and the lactococcus lactis SCB0469 are counted by the number of the viable bacteriaThe ratio of Streptococcus thermophilus to Streptococcus thermophilus is 6.0X 109﹕3.5×109﹕2.0×108
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) adding 42kg of drinking water into 7kg of milk powder, 58kg of fresh soybean milk and 2kg of cane sugar, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milk to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 9.5 multiplied by 109cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature for 12h at the fermentation temperature of 30 ℃; and after fermentation is finished, refrigerating and after-ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating and after-ripening time is more than 12 hours, so as to obtain the bean yoghourt.
Example 4
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises five strains of lactococcus lactis SCB0469, Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, Streptococcus thermophilus and Lactobacillus paracasei, wherein the ratio of the lactococcus lactis SCB0469, the Lactobacillus rhamnosus SCB0119, the Lactobacillus helveticus SCB0641, the Streptococcus thermophilus and the Lactobacillus paracasei is 1.5 multiplied by 10 in terms of the number of active bacteria8﹕6.5×107﹕4.3×108﹕2.0×107﹕7.0×109
The five strains are mixed in proportion to obtain the bean yoghourt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) mixing 32kg of fresh milk, 68kg of fresh soybean milk and 10kg of sucrose, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milk to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 7.6 multiplied by 109cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature, wherein the fermentation temperature is 35 ℃, and the fermentation time is 13.5 hours; and after fermentation is finished, refrigerating and ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating time is more than 12 hours, so that the bean yoghourt is obtained.
Example 5
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactobacillus casei, lactococcus lactis SCB0469 and streptococcus thermophilus, wherein the ratio of the lactobacillus casei, the lactococcus lactis SCB0469 to the streptococcus thermophilus is 4.5 multiplied by 10 in terms of the number of live bacteria9﹕1.5×109﹕4.0×107
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 2, with the only difference that: the inoculum size using this example was 6X 109cfu/L, and the fermentation time is 18h, so that the bean yoghourt is prepared.
Example 6
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactobacillus paracasei, lactococcus lactis SCB0469 and streptococcus thermophilus, wherein the ratio of the lactobacillus paracasei, the lactococcus lactis SCB0469 to the streptococcus thermophilus is 4.5 multiplied by 10 in terms of the number of live bacteria9﹕3.5×108﹕4.0×108
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 3, except that the inoculum size of this example was 5.3X 109cfu/L, and preparing the bean yoghourt.
Example 7
The embodiment provides a bean yogurt adaptive microbial inoculum which comprises three strains of lactobacillus plantarum, lactococcus lactis SCB0469 and streptococcus thermophilusThe ratio of Lactobacillus plantarum to lactococcus lactis SCB0469 to Streptococcus thermophilus was 4.5X 10 in terms of viable count8﹕5.5×109﹕4.0×108
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 3, except that the inoculum size of this example was 5.6X 109cfu/L, fermenting for 18h, and preparing the bean yoghourt.
Example 8
The embodiment provides a bean yogurt adaptive microbial inoculum, which comprises four strains of lactobacillus helveticus SCB0641, lactobacillus paracasei, lactococcus lactis SCB0469 and streptococcus thermophilus, wherein the ratio of the lactobacillus helveticus SCB0641, the lactobacillus paracasei, the lactococcus lactis SCB0469 and the streptococcus thermophilus is 5.0 multiplied by 10 in terms of the number of living bacteria9﹕4.5×108﹕8.5×108﹕1.0×109
The four strains are mixed in proportion to obtain the bean yoghourt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 2, except that the inoculum size of this example was 7.3X 109cfu/L, fermenting for 18h, and preparing the bean yoghourt.
Example 9
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises seven strains of lactobacillus rhamnosus SCB0119, lactobacillus helveticus SCB0641, lactobacillus paracasei, lactobacillus lactis SCB0469, lactobacillus plantarum, lactobacillus casei and streptococcus thermophilus, wherein the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactobacillus paracasei, the lactobacillus lactis SCB0469, the lactobacillus plantarum, the lactobacillus casei and the streptococcus thermophilus is 3.5 multiplied by 10 in terms of the number of the viable bacteria8﹕4.0×109﹕4.5×108﹕1.5×108﹕3.0×108﹕5.5×109﹕1.0×108
Mixing the seven strains in proportion to obtain the bean yoghourt adaptive microbial inoculum.
This example refers to example 2Method for preparing a soy yogurt, the only difference being that the inoculum size used in this example was 1.13X 1010cfu/L, fermenting for 16h, and preparing the bean yoghourt.
Example 10
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises seven strains of lactobacillus rhamnosus SCB0119, lactobacillus helveticus SCB0641, lactobacillus paracasei, lactobacillus lactis SCB0469, lactobacillus plantarum, lactobacillus casei and streptococcus thermophilus, wherein the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactobacillus paracasei SCB0469, the lactobacillus plantarum, the lactobacillus casei and the streptococcus thermophilus is 2.5 multiplied by 10 in terms of the number of live bacteria9﹕4.0×108﹕5.5×109﹕2.5×109﹕5.0×109﹕5.5×108﹕3.0×109
Mixing the seven strains in proportion to obtain the bean yoghourt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 2, except that the total inoculum size using this example is 1.9X 1010cfu/L, fermenting for 16h, and preparing the bean yoghourt.
Comparative example 1
Comparative example 1 the preparation process of example 3 was referenced, except that the inoculated fermentation broth was CGMCC1.16075 and Streptococcus thermophilus CGMCC1.6472 at a ratio of 5.5X 109﹕4.0×109Inoculation amount of 9.5X 109cfu/L。
Experimental example 1
The experimental method comprises the following steps:
the lactococcus lactis (all isolated from kefir) stored in the laboratory was removed from the ultra-low temperature refrigerator and inoculated into 8mL of MRS liquid medium by using a sterile pipette in an inoculum size of 1% (v/v) and cultured at 37 ℃ for 12 hours, and passaging was performed once in the same manner.
Then, the activated liquid strain is inoculated into the mixed soymilk (5% pure soybean powder, 5% whole milk powder, 8% white granulated sugar, pasteurization at 90 ℃ for 20min, cooling to 40 ℃) according to the inoculation amount of 1% (v/v), and placed at 25 ℃ for culturing for 24 h.
And observing and recording the fermentation condition, measuring the pH value of the fermented soybean yoghourt by using a pH meter, observing the curd condition by naked eyes, judging the viscosity by drawing the toothpick, and evaluating the smell of the soybean yoghourt in a sensory manner.
The experimental results are as follows:
experimental example 1 the fermented effect of the soybean yogurt with lactococcus lactis was screened, and the results are shown in Table 1 below.
TABLE 1 screening of fermented Soybean yogurt Strain lactococcus lactis
Figure BDA0002100718070000151
Note: "+" indicates curd, "-" indicates no curd; a sticky condition "+" indicates sticky and "-" indicates not sticky; the savoury soymilk taste is a mixed taste of the flavour of soymilk and the flavour of sour milk in yoghurt.
As can be seen from Table 1, the screened lactococcus lactis fermented soy yogurt at 25 ℃ for 24h, the curd was poor, and only SCB0427 and SCB0469 fermented soy yogurt curds. The strain with stronger acid production is SCB0427, and the pH value is 5.25. The fermented soybean yoghourt has poor viscosity, most of the fermented soybean yoghourt has soybean milk flavor, and the part of the fermented soybean yoghourt has sour and fragrant soybean milk flavor, wherein the fermented soybean milk has the sour and fragrant soybean milk flavor of SCB0427, SCB0431, SCB0433, SCB0449, SCB0469 and SCB 0477. By combining the indexes, the selected SCB0469 fermented soybean yoghourt has better curd effect, the pH values are respectively 5.25 and 5.46, the soybean yoghourt has proper odor, and the soybean yoghourt is suitable for being fermented.
Experimental example 2
Experimental example 2 conditions of aglycone-producing soybean isoflavones and contents of antigen proteins after fermented soybean milk were tested according to different strains, as shown in FIGS. 1 and 2.
The test method comprises the following steps:
soaking soybeans: adding 0.5% NaHCO to the washed soybeans3Soaking the solution at room temperature for 10 hr at a ratio of 1: 3 to make the soybean fully swell.
Blanching: washing the soaked soybeans with distilled water, and blanching at 85-90 deg.C for 10 min.
Grinding: grinding the scalded soybean with beating machine at ratio of 1: 6 for 2min, filtering with 4 layers of gauze, and removing bean dregs.
Sterilization and inoculation fermentation: heating soybean milk to 100 deg.C, boiling for 6min, keeping the temperature at 90 deg.C for 15-20min, cooling to 30 deg.C, inoculating various lactobacillus strains (culture solution after three generations of MRS liquid culture medium activation) according to 2%, shaking, mixing, standing at 25 deg.C, fermenting for 24h, and measuring the contents of two antigen proteins with the fermentation liquid as follows.
The method for measuring the soybean antigenic protein comprises the following steps:
extraction of soybean antigen protein sample: taking 1.0mL of a sample to be detected, soaking the sample in 20.0mL of 0.03mol/L Tris-HCl (pH 8.0 and including 0.01mol/L beta-mercaptoethanol) buffer solution, soaking the sample on a shaking table at the temperature of 28 ℃ for 1h at the speed of 150r/min, then centrifuging the sample at the speed of 4000r/min for 20min, and taking a supernatant for later use.
And (3) detecting the immunological activity: the assay of glycinin was performed according to the method in the purchased antigenic protein ELISA kit (96 wells). Soybean antigenic protein ELISA kit (purchased from Yu duo Biotech, Inc. of Shanghai).
As can be seen from FIG. 1, SCB0641 can significantly increase the content of Daidzein (DE) and Genistin (GE) in fermented soy isoflavone and increase the content of free soy isoflavone aglycone, thereby increasing the bioactivity and bioavailability of soy isoflavone in vivo, compared with other strains.
As can be seen from FIG. 2, SCB0119 can obviously reduce the antigenic contents of two antigenic proteins, namely beta-conglycinin (SPAg) and glycinin (SPA), and the strain can also improve the content of genistin.
Experimental example 3
In order to illustrate the fermentation effect of the microbial inoculum of the invention on the mixed soybean milk, taking example 3 as an example, the content of the soybean isoflavone in the mixed soybean milk before fermentation and the soybean yogurt obtained after fermentation is measured, and the test results are shown in fig. 3-5, fig. 3 is a graph of the content of the soybean isoflavone in the mixed soybean milk before fermentation, fig. 4 is a graph of the content of the soybean isoflavone in the soybean yogurt obtained after fermentation, and fig. 5 is a graph of the change of the content of the soybean isoflavone before and after fermentation. It can be known from the figure that before fermentation, the content of daidzin (D) and genistin (G) is higher, after fermentation, the content of daidzin and genistin is relatively reduced, and meanwhile, the content of Daidzein (DE) and Genistein (GE) is obviously improved, which shows that the microbial inoculum of the invention ferments the mixed soybean milk, can biologically convert the soybean isoflavone, improves the content of free soybean isoflavone aglycone, and further improves the biological activity and bioavailability of the soybean isoflavone in the body.
Experimental example 4
In order to comparatively illustrate the fermentation effect of different microbial agents of the present invention on mixed soybean milk, the content of soybean isoflavone and the degradation of antigen protein in the soybean yogurt obtained by fermentation in examples 1 to 10 and comparative example 1 were tested, and the test results are shown in table 2.
TABLE 2 content of soy isoflavones in different soy yoghurts (unit: μ g/mL soy yoghurt)
Numbering Daidzin Genistin Daidzein Genistein D value
Example 1 78.3±2.7 75.9±1.2 - 0.43±0.04 1.53
Example 2 81.1±4.2 78±0.3 - 0.11±0.02 1.32
Example 3 52.2±2.3 45.9±2.2 12.2±1.2 15.8±2.8 14.52
Example 4 65.3±2.3 69.6±5.4 9.3±0.8 6.9±0.2 1.22
Example 5 82.2±3.4 75.3±4.8 - 0.6±0.04 0.13
Example 6 76.3±4.5 76.8±0.4 0.4±0.04 - -0.05
Example 7 77.3±0.9 75.5±6.2 3.0±0.43 0.4±0.02 0.22
Example 8 57.2±2.9 51.3±0.8 8.3±0.12 10.2±0.44 -0.43
Example 9 60.4±2.2 49.3±4.3 10.2±0.5 14.3±3.2 5.66
Example 10 43.4±3.4 46.2±4.5 16.0±3.2 20.2±4.8 12.26
Comparative example 1 82.3±2.1 76.3±5.4 - - 0.11
Note: calculation of D value: (content of antigen protein in soymilk before fermentation-content of antigen protein in soymilk after fermentation)/content of antigen protein in soymilk before fermentation X100
As can be seen from Table 2, the soy yogurt adaptive strain of the present invention can biologically convert soy isoflavones, significantly increase the content of free soy isoflavone aglycones, and increase the biological activity and bioavailability of soy isoflavones in the body.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
SEQUENCE LISTING
<110> southern China university of agriculture
<120> soy yogurt adaptive strain, microbial inoculum and application thereof
<160> 3
<170> PatentIn version 3.3
<210> 1
<211> 1380
<212> DNA
<213> Lactobacillus rhamnosus
<400> 1
gcttgcatct tgatttaatt ttgaacgagt ggcggacggg tgagtaacac gtgggtaacc 60
tgcccttaag tgggggataa catttggaaa cagatgctaa taccgcataa atccaagaac 120
cgcatggttc ttggctgaaa gatggcgtaa gctatcgctt ttggatggac ccgcggcgta 180
ttagctagtt ggtgaggtaa cggctcacca aggcaatgat acgtagccga actgagaggt 240
tgatcggcca cattgggact gagacacggc ccaaactcct acgggaggca gcagtaggga 300
atcttccaca atggacgcaa gtctgatgga gcaacgccgc gtgagtgaag aaggctttcg 360
ggtcgtaaaa ctctgttgtt ggagaagaat ggtcggcaga gtaactgttg tcggcgtgac 420
ggtatccaac cagaaagcca cggctaacta cgtgccagca gccgcggtaa tacgtaggtg 480
gcaagcgtta tccggattta ttgggcgtaa agcgagcgca ggcggttttt taagtctgat 540
gtgaaagccc tcggcttaac cgaggaagtg catcggaaac tgggaaactt gagtgcagaa 600
gaggacagtg gaactccatg tgtagcggtg aaatgcgtag atatatggaa gaacaccagt 660
ggcgaaggcg gctgtctggt ctgtaactga cgctgaggct cgaaagcatg ggtagcgaac 720
aggattagat accctggtag tccatgccgt aaacgatgaa tgctaggtgt tggagggttt 780
ccgcccttca gtgccgcagc taacgcatta agcattccgc ctggggagta cgaccgcaag 840
gttgaaactc aaaggaattg acgggggccc gcacaagcgg tggagcatgt ggtttaattc 900
gaagcaacgc gaagaacctt accaggtctt gacatctttt gatcacctga gagatcaggt 960
ttccccttcg ggggcaaaat gacaggtggt gcatggttgt cgtcagctcg tgtcgtgaga 1020
tgttgggtta agtcccgcaa cgagcgcaac ccttatgact agttgccagc atttagttgg 1080
gcactctagt aagactgccg gtgacaaacc ggaggaaggt ggggatgacg tcaaatcatc 1140
atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaacg agttgcgaga 1200
ccgcgaggtc aagctaatct cttaaagcca ttctcagttc ggactgtagg ctgcaactcg 1260
cctacacgaa gtcggaatcg ctagtaatcg cggatcagca cgccgcggtg aatacgttcc 1320
cgggccttgt acacaccgcc cgtcacacca tgagagtttg taacacccga agccggtggc 1380
<210> 2
<211> 1419
<212> DNA
<213> Lactococcus lactis
<400> 2
gagcgccctc cttgcggtta ggcaacctac ttcgggtact cccaactccc gtggtgtgac 60
gggcggtgtg tacaaggccc gggaacgtat tcaccgcggc gtgctgatcc gcgattacta 120
gcgattccga cttcatgtag gcgagttgca gcctacaatc cgaactgaga atggttttaa 180
gagattagct aaacatcact gtctcgcgac tcgttgtacc atccattgta gcacgtgtgt 240
agcccaggtc ataaggggca tgatgatttg acgtcatccc caccttcctc cggtttatca 300
ccggcagtct cgttagagtg cccaacttaa tgatggcaac taacaatagg ggttgcgctc 360
gttgcgggac ttaacccaac atctcacgac acgagctgac gacaaccatg caccacctgt 420
atcccgtgtc ccgaaggaac ttcctatctc taggaatagc acgagtatgt caagacctgg 480
taaggttctt cgcgttgctt cgaattaaac cacatgctcc accgcttgtg cgggcccccg 540
tcaattcctt tgagtttcaa ccttgcggtc gtactcccca ggcggagtgc ttattgcgtt 600
agctgcgata cagagaactt atagctccct acatctagca ctcatcgttt acggcgtgga 660
ctaccagggt atctaatcct gtttgctccc cacgctttcg agcctcagtg tcagttacag 720
gccagagagc cgctttcgcc accggtgttc ctccatatat ctacgcattt caccgctaca 780
catggaattc cactctcctc tcctgcactc aagtctacca gtttccaatg catacaatgg 840
ttgagccact gccttttaca ccagacttaa taaaccacct gcgctcgctt tacgcccaat 900
aaatccggac aacgctcggg acctacgtat taccgcggct gctggcacgt agttagccgt 960
ccctttctgg gtagttaccg tcacttgatg agctttccac tctcaccaac gttcttctct 1020
accaacagag ttttacgatc cgaaaacctt cttcactcac gcggcgttgc tcggtcagac 1080
tttcgtccat tgccgaagat tccctactgc tgcctcccgt aggagtttgg gccgtgtctc 1140
agtcccaatg tggccgatca ccctctcagg tcggctatgt atcatcgcct tggtgagcct 1200
ttacctcacc aactagctaa tacaacgcgg gatcatcttt gagtgatgca attgcatctt 1260
tcaaacttaa aacttgtgtt taaagttttt atgcggtatt agcattcgtt tccaaatgtt 1320
gtcccccgct caaaggcaga ttccccacgc gttactcacc cgttcgctgc tcatccagtt 1380
ggtacaagta ccaaccttca gcgctcaact tgcatgtat 1419
<210> 3
<211> 1409
<212> DNA
<213> Lactobacillus helveticus
<400> 3
ggccaccggc tttgggcatt gcagacttcc atggtgtgac gggcggtgtg tacaaggccc 60
gggaacgtat tcaccgcggc gttctgatcc gcgattacta gcgattccag cttcgtgcag 120
tcgagttgca gactgcagtc cgaactgaga acagctttca gagattcgct tgccttcgca 180
ggctcgcttc tcgttgtact gcccattgta gcacgtgtgt agcccaggtc ataaggggca 240
tgatgacttg acgtcatccc caccttcctc cggtttgtca ccggcagtct cattagagtg 300
cccaacttaa tgctggcaac taataataag ggttgcgctc gttgcgggac ttaacccaac 360
atctcacgac acgagctgac gacagccatg caccacctgt cttagcgtcc ccgaagggaa 420
ctcctaatct cttaggatgg cactagatgt caagacctgg taaggttctt cgcgttgctt 480
cgaattaaac cacatgctcc accgcttgtg cgggcccccg tcaattcctt tgagtttcaa 540
ccttgcggtc gtactcccca ggcggagtgc ttaatgcgtt agctgcagca ctgagaggcg 600
gaaacctccc aacacttagc actcatcgtt tacggcatgg actaccaggg tatctaatcc 660
tgttcgctac ccatgctttc gagcctcagc gtcagttgca gaccagagag ccgccttcgc 720
cactggtgtt cttccatata tctacgcatt ccaccgctac acatggagtt ccactctcct 780
cttctgcact caagaaaaac agtttccgat gcaattcctc ggttaagccg agggctttca 840
catcagactt attcttccgc ctgcgctcgc tttacgccca ataaatccgg acaacgcttg 900
ccacctacgt attaccgcgg ctgctggcac gtagttagcc gtgactttct ggttgattac 960
cgtcaaataa aggccagtta ctacctctat ccttcttcac caacaacaga gctttacgat 1020
ccgaaaacct tcttcactca cgcggcgttg ctccatcaga cttgcgtcca ttgtggaaga 1080
ttccctactg ctgcctcccg taggagtttg ggccgtgtct cagtcccaat gtggccgttc 1140
agtctctcaa ctcggctatg catcattgcc ttggtaagcc gttaccttac caactagcta 1200
atgcaccgcg gggccatccc atagcgacag cttacgccgc cttttataag ctgatcatgc 1260
gatctgcttt attatccggt attagcacct gtttccaagt ggtatcctag actatggggc 1320
aggttcccca cgtgttactc acccatccgc cgctcgcgtc cccagcgtca ttaccgaagt 1380
aaatctgctg gttctgctcg ctcgacttg 1409

Claims (42)

1.豆酸奶适制性菌株,其特征在于,所述菌株为:1. soy yogurt suitable bacterial strain, is characterized in that, described bacterial strain is: a)乳酸乳球菌(Lactococcus lactis)SCB0469,保藏于中国微生物菌种保藏中心,保藏编号为:CGMCC17619;保藏时间为:2019年4月24日。a) Lactococcus lactis SCB0469, deposited in the China Microbial Culture Collection Center, the preservation number is: CGMCC17619; the preservation time is: April 24, 2019. 2.包含权利要求1所述的豆酸奶适制性菌株的菌剂。2. The inoculum comprising the soy yogurt-suitable strain of claim 1. 3.根据权利要求2所述的菌剂,其特征在于,所述菌剂中还包括以下菌株中的任一种或两种;3. microbial inoculum according to claim 2, is characterized in that, also comprises any one or both in following bacterial strain in described microbial inoculum; b)鼠李糖乳杆菌(Lactobacillus rhamnosus)SCB0119,保藏于中国微生物菌种保藏中心,保藏编号为:CGMCC17618;保藏时间为:2019年4月24日;b) Lactobacillus rhamnosus SCB0119, deposited in the China Microbial Culture Collection Center, preservation number: CGMCC17618; preservation time: April 24, 2019; c)瑞士乳杆菌(Lactobacillus helveticus)SCB0641,保藏于中国微生物菌种保藏中心,保藏编号为:CGMCC17620;保藏时间为:2019年4月24日。c) Lactobacillus helveticus SCB0641, deposited in the China Microbial Culture Collection Center, with the preservation number: CGMCC17620; preservation time: April 24, 2019. 4.根据权利要求2或3所述的菌剂,其特征在于,还包括嗜热链球菌、植物乳杆菌、干酪乳杆菌、副干酪乳杆菌中的任一种或多种。4. The bacterial agent according to claim 2 or 3, further comprising any one or more of Streptococcus thermophilus, Lactobacillus plantarum, Lactobacillus casei, and Lactobacillus paracasei. 5.根据权利要求4所述的菌剂,其特征在于,所述菌剂中,以活菌数计,鼠李糖乳杆菌SCB0119、乳酸乳球菌SCB0469和瑞士乳杆菌SCB0641的比为(0~1.22×1010)﹕(1.0×106~3.60×1010)﹕(0~8.55×1010)。5. microbial inoculum according to claim 4 is characterized in that, in the described microbial inoculum, in terms of viable count, the ratio of Lactobacillus rhamnosus SCB0119, Lactococcus lactis SCB0469 and Lactobacillus helveticus SCB0641 is (0~ 1.22×10 10 ): (1.0×10 6 to 3.60×10 10 ): (0 to 8.55×10 10 ). 6.根据权利要求4所述的菌剂,其特征在于,所述菌剂中,以活菌数计,鼠李糖乳杆菌SCB0119、乳酸乳球菌SCB0469、瑞士乳杆菌SCB0641、嗜热链球菌的比为(0~1.22×1010)﹕(1.0×106~3.60×1010)﹕(0~8.55×1010)﹕(1.0×106~4.54×109)。6. microbial inoculum according to claim 4, is characterized in that, in described microbial inoculum, counted by viable count, lactobacillus rhamnosus SCB0119, lactococcus lactis SCB0469, lactobacillus helveticus SCB0641, streptococcus thermophilus The ratio is (0~1.22×10 10 ):(1.0×10 6 ~3.60×10 10 ):(0~8.55×10 10 ):(1.0×10 6 ~4.54×10 9 ). 7.根据权利要求3所述的菌剂,其特征在于,所述菌剂中,包括鼠李糖乳杆菌SCB0119、瑞士乳杆菌SCB0641、乳酸乳球菌SCB0469和副干酪乳酸菌。7 . The bacterial agent according to claim 3 , wherein the bacterial agent comprises Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, Lactococcus lactis SCB0469 and Lactobacillus paracasei. 8 . 8.根据权利要求7所述的菌剂,其特征在于,所述菌剂中,以活菌数计,鼠李糖乳杆菌SCB0119、瑞士乳杆菌SCB0641、乳酸乳球菌SCB0469、副干酪乳杆菌的比为(6.5×107~3.0×109)﹕(1.5×108~5.0×109)﹕(1.5×108~3.0×109)﹕(4.0×108~7.5×109)。8. microbial inoculum according to claim 7, is characterized in that, in described microbial inoculum, counted by viable count, Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, Lactococcus lactis SCB0469, Lactobacillus paracasei The ratio is (6.5×10 7 ~3.0×10 9 ): (1.5×10 8 ~5.0×10 9 ): (1.5×10 8 ~3.0×10 9 ): (4.0×10 8 ~7.5×10 9 ). 9.根据权利要求7所述的菌剂,其特征在于,所述菌剂中还包括嗜热链球菌。The microbial inoculum according to claim 7, characterized in that, the microbial inoculum further comprises Streptococcus thermophilus. 10.根据权利要求9所述的菌剂,其特征在于,所述菌剂中,以活菌数计,鼠李糖乳杆菌SCB0119、瑞士乳杆菌SCB0641、乳酸乳球菌SCB0469、副干酪乳杆菌、嗜热链球菌的比为(6.5×107~2.5×109)﹕(4.0×108~4.0×109)﹕(1.5×108~2.5×109)﹕(4.5×108~7.0×109)﹕(2.0×107~3.0×109)。10. microbial inoculum according to claim 9, is characterized in that, in described microbial inoculum, by viable count, Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, Lactococcus lactis SCB0469, Lactobacillus paracasei, The ratio of Streptococcus thermophilus was (6.5×10 7 ~2.5×10 9 ): (4.0×10 8 ~4.0×10 9 ):(1.5×10 8 ~2.5×10 9 ):(4.5×10 8 ~7.0 ×10 9 ): (2.0×10 7 to 3.0×10 9 ). 11.根据权利要求9所述的菌剂,其特征在于,所述菌剂中还包括植物乳杆菌和/或干酪乳杆菌。11. The inoculum according to claim 9, wherein the inoculum also comprises Lactobacillus plantarum and/or Lactobacillus casei. 12.根据权利要求11所述的菌剂,其特征在于,所述菌剂中,以活菌数计,鼠李糖乳杆菌SCB0119、瑞士乳杆菌SCB0641、乳酸乳球菌SCB0469、副干酪乳杆菌、嗜热链球菌、植物乳杆菌、干酪乳杆菌的比为(6.5×107~2.5×109)﹕(4.0×108~4.0×109)﹕(1.5×108~2.5×109)﹕(4.5×108~7.0×109)﹕(2.0×107~3.0×109)﹕(3.0×108~5.0×109)﹕(5.5×108~5.5×109)。12. microbial inoculum according to claim 11, is characterized in that, in described microbial inoculum, by viable count, Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, Lactococcus lactis SCB0469, Lactobacillus paracasei, The ratio of Streptococcus thermophilus, Lactobacillus plantarum and Lactobacillus casei is (6.5×10 7 ~2.5×10 9 ): (4.0×10 8 ~4.0×10 9 ): (1.5×10 8 ~2.5×10 9 ) : (4.5×10 8 to 7.0×10 9 ): (2.0×10 7 to 3.0×10 9 ): (3.0×10 8 to 5.0×10 9 ): (5.5×10 8 to 5.5×10 9 ). 13.根据权利要求3所述的菌剂,其特征在于,所述菌剂中,包括乳酸乳球菌SCB0469和瑞士乳杆菌SCB0641。The microbial inoculum according to claim 3, wherein the microbial inoculum comprises Lactococcus lactis SCB0469 and Lactobacillus helveticus SCB0641. 14.根据权利要求13所述的菌剂,其特征在于,所述菌剂中,以活菌数计,乳酸乳球菌SCB0469、瑞士乳杆菌SCB0641的比为(1×107~2.5×109)﹕(1.5×107~4.0×109)。The microbial inoculum according to claim 13, characterized in that, in the microbial inoculum, the ratio of Lactococcus lactis SCB0469 to Lactobacillus helveticus SCB0641 is (1×10 7 to 2.5×10 9 in terms of viable cell counts) ): (1.5×10 7 to 4.0×10 9 ). 15.根据权利要求13所述的菌剂,其特征在于,所述菌剂中,还包括嗜热链球菌。The microbial inoculum according to claim 13, wherein the microbial inoculum further comprises Streptococcus thermophilus. 16.根据权利要求15所述的菌剂,其特征在于,所述菌剂中,以活菌数计,乳酸乳球菌SCB0469、瑞士乳杆菌SCB0641、嗜热链球菌的比为(1×107~2.5×109)﹕(1.5×107~4.0×109)﹕(3×106~3×109)。16. microbial inoculum according to claim 15, is characterized in that, in described microbial inoculum, by viable count, the ratio of Lactococcus lactis SCB0469, Lactobacillus helveticus SCB0641, Streptococcus thermophilus is (1 × 10 7 ~2.5×10 9 ): (1.5×10 7 ~4.0×10 9 ): (3×10 6 ~3×10 9 ). 17.根据权利要求13所述的菌剂,其特征在于,所述菌剂中,还包括副干酪乳杆菌。17. The bacterial preparation according to claim 13, wherein the bacterial preparation further comprises Lactobacillus paracasei. 18.根据权利要求17所述的菌剂,其特征在于,所述菌剂中,以活菌数计,瑞士乳杆菌SCB0641、副干酪乳杆菌、乳酸乳球菌SCB0469的比为(3.0×108~5.0×109):(4.0×108~5.5×109)﹕(1.5×108~2.5×109)。18. microbial inoculum according to claim 17, is characterized in that, in described microbial inoculum, by viable count, the ratio of Lactobacillus helveticus SCB0641, Lactobacillus paracasei, Lactococcus lactis SCB0469 is (3.0×10 8 ~5.0×10 9 ): (4.0×10 8 ~5.5×10 9 ): (1.5×10 8 ~2.5×10 9 ). 19.根据权利要求3所述的菌剂,其特征在于,所述菌剂中,包括鼠李糖乳杆菌SCB0119和乳酸乳球菌SCB0469。The microbial inoculum according to claim 3, wherein the microbial inoculum comprises Lactobacillus rhamnosus SCB0119 and Lactococcus lactis SCB0469. 20.根据权利要求19所述的菌剂,其特征在于,所述菌剂中,以活菌数计,鼠李糖乳杆菌SCB0119和乳酸乳球菌SCB0469的比为(6.5×107~6×109)﹕(1.5×108~3.5×109)。20 . The bacterial agent according to claim 19 , wherein, in the bacterial agent, the ratio of Lactobacillus rhamnosus SCB0119 to Lactococcus lactis SCB0469 is (6.5×10 7 to 6× 10 9 ): (1.5×10 8 to 3.5×10 9 ). 21.根据权利要求19所述的菌剂,其特征在于,所述菌剂中,还包括嗜热链球菌。21. The bacterial agent according to claim 19, wherein the bacterial agent further comprises Streptococcus thermophilus. 22.根据权利要求21所述的菌剂,其特征在于,所述菌剂中,以活菌数计,鼠李糖乳杆菌SCB0119、乳酸乳球菌SCB0469、嗜热链球菌的比为(6.5×107~6×109)﹕(1.5×108~3.5×109)﹕(2×107~3×109)。22. The microbial inoculum according to claim 21, wherein in the microbial inoculum, the ratio of Lactobacillus rhamnosus SCB0119, Lactococcus lactis SCB0469, and Streptococcus thermophilus is (6.5× 10 7 to 6×10 9 ): (1.5×10 8 to 3.5×10 9 ): (2×10 7 to 3×10 9 ). 23.根据权利要求2所述的菌剂,其特征在于,所述菌剂中,包括干酪乳杆菌和乳酸乳球菌SCB0469。23. The bacterial agent according to claim 2, wherein the bacterial agent comprises Lactobacillus casei and Lactococcus lactis SCB0469. 24.根据权利要求23所述的菌剂,其特征在于,所述菌剂中,以活菌数计,干酪乳杆菌、乳酸乳球菌SCB0469的比为(4×108~8×109)﹕(1×108~2.5×109)。24. The bacterial agent according to claim 23, wherein, in the bacterial agent, the ratio of Lactobacillus casei and Lactococcus lactis SCB0469 is (4×10 8 to 8×10 9 ) in terms of viable count. : (1×10 8 to 2.5×10 9 ). 25.根据权利要求23所述的菌剂,其特征在于,所述菌剂中,还包括嗜热链球菌。25. The bacterial agent according to claim 23, wherein the bacterial agent further comprises Streptococcus thermophilus. 26.根据权利要求25所述的菌剂,其特征在于,所述菌剂中,以活菌数计,干酪乳杆菌、乳酸乳球菌SCB0469和嗜热链球菌比为(5.5×108~5.5×109)﹕(1.5×108~2.5×109)﹕(4.0×107~3.0×109)。The microbial inoculum according to claim 25, characterized in that, in the microbial inoculum, the ratio of Lactobacillus casei, Lactococcus lactis SCB0469 and Streptococcus thermophilus is (5.5×10 8 ~ 5.5 in terms of viable counts) ×10 9 ): (1.5×10 8 to 2.5×10 9 ): (4.0×10 7 to 3.0×10 9 ). 27.根据权利要求2所述的菌剂,其特征在于,所述菌剂中,包括副干酪乳杆菌和乳酸乳球菌SCB0469。27. The bacterial agent according to claim 2, wherein the bacterial agent comprises Lactobacillus paracasei and Lactococcus lactis SCB0469. 28.根据权利要求27所述的菌剂,其特征在于,所述菌剂中,以活菌数计,副干酪乳杆菌、乳酸乳球菌SCB0469的比为(3.0×108~7.0×109)﹕(1.5×108~2.5×109)。28. The bacterial preparation according to claim 27, wherein in the bacterial preparation, the ratio of Lactobacillus paracasei and Lactococcus lactis SCB0469 is (3.0 × 10 8 to 7.0 × 10 9 in terms of viable counts) ): (1.5×10 8 to 2.5×10 9 ). 29.根据权利要求27所述的菌剂,其特征在于,所述菌剂中,还包括嗜热链球菌。29. The bacterial agent according to claim 27, wherein the bacterial agent further comprises Streptococcus thermophilus. 30.根据权利要求29所述的菌剂,其特征在于,所述菌剂中,以活菌数计,副干酪乳杆菌、乳酸乳球菌SCB0469和嗜热链球菌比为(4.5×108~7.0×109)﹕(1.5×108~2.5×109)﹕(2.0×107~3.0×109)。30. The bacterial agent according to claim 29, wherein, in the bacterial agent, the ratio of Lactobacillus paracasei, Lactococcus lactis SCB0469 and Streptococcus thermophilus is (4.5×10 8 ~ 7.0×10 9 ): (1.5×10 8 to 2.5×10 9 ): (2.0×10 7 to 3.0×10 9 ). 31.根据权利要求2所述的菌剂,其特征在于,所述菌剂中,包括植物乳杆菌和乳酸乳球菌SCB0469。31. The inoculum according to claim 2, wherein the inoculum comprises Lactobacillus plantarum and Lactococcus lactis SCB0469. 32.根据权利要求31所述的菌剂,其特征在于,所述菌剂中,以活菌数计,植物乳杆菌、乳酸乳球菌SCB0469的比为(3.0×108~8.0×109)﹕(1.5×108~8.0×109)。32. The bacterial agent according to claim 31, wherein, in the bacterial agent, the ratio of Lactobacillus plantarum and Lactococcus lactis SCB0469 is (3.0×10 8 to 8.0×10 9 ) in terms of the number of viable cells. : (1.5×10 8 to 8.0×10 9 ). 33.根据权利要求31所述的菌剂,其特征在于,所述菌剂中,还包括嗜热链球菌。33. The bacterial agent according to claim 31, wherein the bacterial agent further comprises Streptococcus thermophilus. 34.根据权利要求33所述的菌剂,其特征在于,所述菌剂中,以活菌数计,植物乳杆菌、乳酸乳球菌SCB0469和嗜热链球菌比为(3.0×108~5.0×109)﹕(1.5×108~5.5×109)﹕(1.0×108~3.0×109)。34. The bacterial agent according to claim 33, wherein, in the bacterial agent, the ratio of Lactobacillus plantarum, Lactococcus lactis SCB0469 and Streptococcus thermophilus is (3.0×10 8 -5.0 ×10 9 ): (1.5×10 8 to 5.5×10 9 ): (1.0×10 8 to 3.0×10 9 ). 35.权利要求2-34中任一项所述的菌剂在豆酸奶制作中的应用。35. The application of the bacterial agent according to any one of claims 2-34 in the production of soy yogurt. 36.根据权利要求35所述的应用,其特征在于,所述豆酸奶制作的方法包括:在灭菌后的混合豆乳中接种所述菌剂,进行发酵。36 . The application according to claim 35 , wherein the method for making the soy yogurt comprises: inoculating the microbial inoculum in the sterilized mixed soy milk to ferment. 37 . 37.根据权利要求36所述的应用,其特征在于,所述菌剂在混合豆乳中的接种量为3.0×107~9.6×1010cfu/L。37. The application according to claim 36, wherein the inoculum of the bacterial agent in the mixed soymilk is 3.0×10 7 to 9.6×10 10 cfu/L. 38.根据权利要求36所述的应用,其特征在于,所述发酵的温度为25-45℃;所述发酵的时间为5-24h。38. The application according to claim 36, wherein the fermentation temperature is 25-45°C; and the fermentation time is 5-24h. 39.根据权利要求36所述的应用,其特征在于,所述混合豆乳主要由奶基质、豆基质混合制成。39. The application according to claim 36, wherein the mixed soymilk is mainly made by mixing a milk base and a bean base. 40.根据权利要求39所述的应用,其特征在于,所述混合豆乳中还包括甜味剂。40. The application according to claim 39, wherein the mixed soymilk further comprises a sweetener. 41.根据权利要求39所述的应用,其特征在于,所述奶基质包括鲜牛奶、奶粉和炼奶中的任一种或多种。41. The use according to claim 39, wherein the milk base comprises any one or more of fresh milk, milk powder and condensed milk. 42.根据权利要求39所述的应用,其特征在于,所述豆基质包括鲜豆乳、豆粉中的任一种或多种。42. The application according to claim 39, wherein the bean base comprises any one or more of fresh soybean milk and soybean flour.
CN201910534345.8A 2019-06-20 2019-06-20 Soy yogurt suitable strains, inoculants and their applications Active CN110129243B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910534345.8A CN110129243B (en) 2019-06-20 2019-06-20 Soy yogurt suitable strains, inoculants and their applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910534345.8A CN110129243B (en) 2019-06-20 2019-06-20 Soy yogurt suitable strains, inoculants and their applications

Publications (2)

Publication Number Publication Date
CN110129243A CN110129243A (en) 2019-08-16
CN110129243B true CN110129243B (en) 2021-02-23

Family

ID=67578818

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910534345.8A Active CN110129243B (en) 2019-06-20 2019-06-20 Soy yogurt suitable strains, inoculants and their applications

Country Status (1)

Country Link
CN (1) CN110129243B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200007118A1 (en) * 2022-04-11 2023-10-11 Univ Degli Studi Di Firenze LACTIC BACTERIA FOR THE PREPARATION OF DRINKS OR VEGETABLE FOODS ENRICHED IN G-AMINOBUTYRIC ACID

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111197018B (en) * 2020-01-13 2020-11-06 河北农业大学 Lactobacillus acidi, method for fermenting soybean milk with the same, and prepared fermented soybean milk and application
CN111616227A (en) * 2020-03-30 2020-09-04 华南农业大学 A kind of physalis tofu rich in aglycone isoflavones and preparation method thereof
CN111602721A (en) * 2020-05-08 2020-09-01 华南农业大学 A kind of method for promoting fermentation of plant yogurt and application thereof
CN115873749B (en) * 2022-08-22 2024-05-03 黑龙江飞鹤乳业有限公司 Microbial inoculum, fermented plant-based yoghurt and preparation method thereof
CN115386523B (en) * 2022-09-30 2024-01-30 北京诺安百汇医药科技有限公司 Lactococcus lactis and application thereof in resisting helicobacter pylori infection
CN116138400A (en) * 2023-01-04 2023-05-23 广东鸿景农业科技有限公司 Soybean yoghurt fermented by new soybean varieties and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103355406B (en) * 2013-06-20 2015-08-19 宁波大学 A kind of production method being rich in active polysaccharide Fermented Soybean Milk

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200007118A1 (en) * 2022-04-11 2023-10-11 Univ Degli Studi Di Firenze LACTIC BACTERIA FOR THE PREPARATION OF DRINKS OR VEGETABLE FOODS ENRICHED IN G-AMINOBUTYRIC ACID

Also Published As

Publication number Publication date
CN110129243A (en) 2019-08-16

Similar Documents

Publication Publication Date Title
CN110129243B (en) Soy yogurt suitable strains, inoculants and their applications
US4702923A (en) Lyophilized kefir yoghurt health food
CN101861895B (en) Method for preparing novel fermented soybean milk products
CN102422882B (en) Soybean-honey acidophilus milk and preparation method thereof
CN110106119B (en) Lactobacillus rhamnosus M9 separated from breast milk and application thereof
CZ291067B6 (en) Lactobacillus helveticus bacterium producing lactic acid, fermented milk product and process for preparing thereof
CN109517763B (en) Lactobacillus helveticus H11 and application thereof
CN104305465B (en) The preparation method of lactic acid bacteria fermentation type blue berry fruit juice
CN102986872A (en) Fermented egg yoghurt containing chickpeas and method for preparing egg yoghurt
CN111955548B (en) Pure probiotic flavored fermented milk and preparation method thereof
CN115261264A (en) Lactobacillus paracasei PC804 and application thereof
CN112852684B (en) Lactobacillus plantarum strain Y388 and application thereof
CN109337833B (en) Biological preparation of mutagenic leuconostoc mesenteroides and application thereof
CN102697010B (en) A kind of fermented vegetables and preparation method thereof
KR100882278B1 (en) Soybean yoghurt fermented with kimchi lactic acid bacteria and its manufacturing method
CN101223911A (en) Mushroom yoghurt and its production process
JP2010505390A (en) Use of gum arabic to improve the growth and survival of bifidobacteria
CN110250270B (en) A kind of method that utilizes Lactobacillus plantarum to improve fermented milk folic acid content
CN113693205A (en) Healthy flavored soybean milk formula and production process thereof
CN109266572B (en) Lactobacillus casei mutant strain for producing glutamine transaminase and application thereof
CN107099482A (en) A kind of Pediococcus pentosaceus and its application
CN109504636A (en) A kind of lactobacillus plantarum P12 and application thereof
CN109430402A (en) A kind of preparation method of fermented type oat dairy products
KR101022797B1 (en) Method for preparing soymilk yogurt using soybean water and mixed lactic acid bacteria and soymilk yogurt prepared thereby
KR20120003573A (en) Enterococcus faecalis having an intestinal flora normalizing effect, fermented product comprising the same, and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant